In a first for the U.S. Food and Drug Administration (FDA), the genetic testing company 23andMe is being given permission to sell genetic tests for disease risks.

The Florida House of Representatives is asking the state’s hospitals for “extensive financial data,” according to the Tampa Bay Times, as the chamber considers a state budget with nearly $600 million in cuts affecting those facilities. 

The average monthly premium for a benchmark silver-level plan on the Affordable Care Act (ACA) insurance marketplace would need to be increased by 19 percent to compensate for lost cost-sharing subsides if the program isn’t funded by the Republican-controlled Congress for 2018.

Performance on patient experience scores can impact the cash flow and operating profit margins of hospitals, which may mean organizations have to align quality metrics and leadership to influence patients’ perceptions of their care.

Faster approval of drugs doesn’t have to mean sacrificing safety, according to Scott Gottlieb, MD, the nominee for commissioner for the U.S. Food and Drug Administration (FDA).

Providing rheumatoid arthritis patients with a simple pedometer has shown to increased daily activity and decrease fatigue, according to a study published in Arthritis Care & Research. 

The Pharmaceutical Research and Manufacturers of America (PhRMA) today unveiled "Share the Savings," a new campaign to educate the public about the lack of rebate pass-through for commercially insured patients with high deductibles and coinsurance.

Cardinal Health is in exclusive talks to acquire the medical supplies business of Medtronic for $6 billion, sources told Reuters on April 5.